Mandate

Vinge advises Re:NewCell on its IPO

Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Market.

The company is the first in the world to commercially offer a dissolving pulp for textile production manufactured from 100 per cent recycled textiles.

The Vinge team includes Christian Lindhé, Erik Sjöman, Ludvig Frithiof and Nora Gullberg (Capital Markets and Public M&A), Henrik Ossborn and Jack Bengtsson (Banking and Finance), Anna Edström and Martin Svanberg (M&A) as well as Maria Schultzberg (Tax).

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024